Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
81.14 USD  +1.05 (+1.31%)
Official Closing Price  /  Updated: 6:40 PM EDT, Apr 25, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,379,027
Open 80.27
Bid (Size) 78.00 (100)
Ask (Size) 81.65 (200)
Prev. Close 80.09
Today's Range 80.01 - 82.32
52wk Range 73.69 - 89.09
Shares Outstanding 1,092,700,369
Dividend Yield 2.62%
Performance
YTD
-4.18%
-4.18%
1 Month
+6.51%
+6.51%
3 Month
-3.89%
-3.89%
6 Month
-4.73%
-4.73%
1 Year
-2.73%
-2.73%
Featured News
More News
A one-way bet could end in a steep selloff for this commodity
Our chart of the day shows that the consensus bet for a weak dollar is still going strong, but there’s another side of the market that expects the opposite will happen. And that could crush one big... Read More
category AAPL , Internet , Pharmaceuticals , and 41 more.
from MarketWatch
Do drug prices affect CEO pay? Faith-based investor group wants to know
The group says executives may be too focused on revenue to care enough about the risks posed by high drug prices. Read More
category ABBV , Medical Products , XPH , and 14 more.
from MarketWatch
Featured News
Read More
Box CEO on Dropbox IPO: We’re like Salesforce, they’re like Netflix
category WDAY , Software , LLY , and 13 more.
from MarketWatch
Drug companies are beginning to wake up to this new risk factor
category AMGN , Pharmaceuticals , General , and 15 more.
from MarketWatch
Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble
category Medical Products , General , Pharmaceuticals , and 7 more.
from MarketWatch
Teva drops 8% on guidance, manufacturing problems
category NVS , Medical Products , Pharmaceuticals , and 12 more.
from MarketWatch
The case against Apple in this Teflon rally
category GCH8 , LLY , BRK/B , and 39 more.
from MarketWatch
Dow set to stabilize after shedding 540 points in 2 days
category ESH8 , DXY , Pharmaceuticals , and 25 more.
from MarketWatch
More News
Read More
Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
from PR Newswire
Lilly Reports Strong First-Quarter 2018 Results, Raises EPS Guidance
from PR Newswire
Eli Lilly Tops Earnings Views, Raises Guidance
from Investor's Business Daily
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
from PR Newswire
HDV, UPS, LLY, D: Large Outflows Detected at ETF
category ETFs
from ETF Channel
BRIEF-Lilly And China's NCCD Announce Collaboration To Advance Scientific Understanding And Care For People Living With Diabetes And Cardiovascular Disease
category companyNews
from Reuters: Company News
Watch for Shares of Eli Lilly & Co (LLY) to Approach Resistance at $82.75
from Comtex SmarTrend® News Briefs
FOCUS-Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
category companyNews
from Reuters: Company News
Why the market is blowing off what has been a really good earnings season
category Investing , Caterpillar Inc , S&P 500 Index , and 6 more.
from CNBC.com News
Goldman Sachs Neutral On Alder Biopharma As Launch Of Migraine Treatment Approaches
category Analyst Color , LLY , TEVA , and 10 more.
from Benzinga
Is Eli Lilly and Company a Buy?
category INCY , LLY
from Motley Fool
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial

WHAT'S POPULAR IN THE VILLE